SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001395064-23-000143
Filing Date
2023-11-30
Accepted
2023-11-30 06:01:17
Documents
10
Period of Report
2023-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k_113023.htm 6-K 11735
2 EX-99.1 interimbusinessreport.htm EX-99.1 25368
3 GRAPHIC interimbusinessreport001.jpg GRAPHIC 119348
4 GRAPHIC interimbusinessreport002.jpg GRAPHIC 264667
5 GRAPHIC interimbusinessreport003.jpg GRAPHIC 272768
6 GRAPHIC interimbusinessreport004.jpg GRAPHIC 318827
7 GRAPHIC interimbusinessreport005.jpg GRAPHIC 408874
8 GRAPHIC interimbusinessreport006.jpg GRAPHIC 235309
9 GRAPHIC interimbusinessreport007.jpg GRAPHIC 301804
10 GRAPHIC interimbusinessreport008.jpg GRAPHIC 194738
  Complete submission text file 0001395064-23-000143.txt   2953627
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 231453874
SIC: 2834 Pharmaceutical Preparations